Toronto Dominion Bank’s Lexaria Bioscience LEXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Hold
9,334
﹤0.01% 1667
2025
Q4
$86.5K Hold
9,334
﹤0.01% 1587
2025
Q3
$133K Buy
9,334
+459
+5% +$6.66K ﹤0.01% 1456
2025
Q2
$116K Buy
8,875
+207
+2% +$3.56K ﹤0.01% 1365
2025
Q1
$222K Buy
+8,668
New +$221K ﹤0.01% 1250
2024
Q3
Sell
-1
Closed -$36 1318
2024
Q2
$36 Hold
1
﹤0.01% 1403
2024
Q1
$47 Hold
1
﹤0.01% 1374
2023
Q4
$16 Hold
1
﹤0.01% 1548
2023
Q3
$13 Hold
1
﹤0.01% 1800
2023
Q2
$0 Hold
1
﹤0.01% 1657
2023
Q1
$0 Buy
+1
New +$43 ﹤0.01% 1599

Other funds holding LEXX

Toronto Dominion Bank's LEXX Position: Q1 2026 in Review

Toronto Dominion Bank held its Lexaria Bioscience (LEXX) position steady in Q1 2026 at 9,334 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Toronto Dominion Bank first reported a position in LEXX in Q1 2023 and has held it in 11 quarters since. The position peaked at $222K in Q1 2025. 25 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Toronto Dominion Bank held 9,334 shares of Lexaria Bioscience worth $109K as of Q1 2026.
  • Toronto Dominion Bank left its Lexaria Bioscience share count unchanged in Q1 2026.
  • Lexaria Bioscience made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1667 holding.
  • Toronto Dominion Bank first reported a position in Lexaria Bioscience in Q1 2023 and has held it in 11 quarters since.
  • Toronto Dominion Bank's Lexaria Bioscience position peaked at $222K in Q1 2025.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.